Integer Holdings Co. (NYSE:ITGR) Receives $146.56 Consensus Target Price from Analysts

Integer Holdings Co. (NYSE:ITGR) has been given a consensus rating of “Moderate Buy” by the nine ratings firms that are currently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $147.67.

Several brokerages have commented on ITGR. Oppenheimer downgraded shares of Integer from an “outperform” rating to a “market perform” rating in a research report on Friday. Wells Fargo & Company restated an “overweight” rating and set a $160.00 price objective on shares of Integer in a research report on Tuesday, December 3rd. Truist Financial lifted their target price on Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Benchmark boosted their target price on Integer from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Friday. Finally, KeyCorp raised their price target on shares of Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research note on Friday, January 24th.

Integer Stock Performance

ITGR opened at $129.96 on Friday. The firm has a market cap of $4.36 billion, a P/E ratio of 40.11, a price-to-earnings-growth ratio of 1.82 and a beta of 1.13. The business’s fifty day moving average is $137.92 and its 200-day moving average is $132.31. Integer has a 52-week low of $98.63 and a 52-week high of $146.36. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28.

Integer (NYSE:ITGR) last released its earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing the consensus estimate of $1.46 by ($0.03). Integer had a net margin of 6.70% and a return on equity of 11.63%. The firm had revenue of $449.50 million during the quarter, compared to the consensus estimate of $446.28 million. Sell-side analysts expect that Integer will post 5.33 EPS for the current fiscal year.

Hedge Funds Weigh In On Integer

Large investors have recently modified their holdings of the business. Mather Group LLC. grew its stake in shares of Integer by 304.3% in the fourth quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 143 shares during the last quarter. Lee Danner & Bass Inc. acquired a new position in Integer during the 4th quarter worth about $27,000. Huntington National Bank grew its position in shares of Integer by 8,933.3% in the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after buying an additional 268 shares during the last quarter. R Squared Ltd acquired a new stake in shares of Integer in the fourth quarter valued at about $44,000. Finally, Sterling Capital Management LLC raised its position in shares of Integer by 472.9% during the fourth quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider’s stock worth $45,000 after acquiring an additional 279 shares during the last quarter. Institutional investors own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.